Forte Biosciences, Inc. (NASDAQ:FBRX – Get Free Report) was the target of unusually large options trading activity on Wednesday. Investors bought 30,205 call options on the company. This is an increase of approximately 1,663% compared to the typical daily volume of 1,713 call options.
Forte Biosciences Trading Down 4.1 %
FBRX stock opened at $4.45 on Friday. The business’s 50 day simple moving average is $5.46 and its 200 day simple moving average is $1.91. Forte Biosciences has a 1-year low of $4.25 and a 1-year high of $21.25. The firm has a market capitalization of $6.50 million, a PE ratio of -0.24 and a beta of 0.01.
Forte Biosciences (NASDAQ:FBRX – Get Free Report) last posted its earnings results on Wednesday, August 14th. The company reported ($0.27) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.16) by ($0.11). As a group, sell-side analysts predict that Forte Biosciences will post -22.5 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
Get Our Latest Stock Report on FBRX
About Forte Biosciences
Forte Biosciences, Inc operates as a biopharmaceutical company in the United States. The company is developing FB-102 program that addresses various autoimmune diseases, such as graft-versus-host disease, and vitiligo and alopecia areata. Forte Biosciences, Inc is headquartered in Dallas, Texas.
Featured Stories
- Five stocks we like better than Forte Biosciences
- What Are Dividends? Buy the Best Dividend Stocks
- Microsoft Can Hit New All-Time Highs This Year – Here’s Why
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Zillow Stock’s Bull Case: Why This Recent Sell-Off Could Be a Buy
- Low PE Growth Stocks: Unlocking Investment Opportunities
- IonQ’s Quantum Surge: Ride the Wave or Cash Out?
Receive News & Ratings for Forte Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Forte Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.